华润三九：益气清肺颗粒首次纳入医保目录

Core Viewpoint - China Resources Sanjiu announced that its drug Yiqi Qingfei Granules has been included in the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List (2025) through negotiations, marking a significant milestone for the company [1] Group 1: Drug Registration and Classification - Yiqi Qingfei Granules is classified as a Traditional Chinese Medicine (TCM) under category 3.2, with a dosage form of granules [1] - The drug received its registration certificate from the National Medical Products Administration in January 2025 [1] Group 2: Agreement and Validity - The agreement for inclusion in the insurance drug list is effective from January 1, 2026, to December 31, 2027 [1] - The indications for Yiqi Qingfei Granules include nourishing Qi and Yin, strengthening the spleen, and clearing heat and dampness [1] Group 3: Market Activities - The company is currently engaged in post-marketing academic promotion and related activities for online sales [1]